Objective: Zfp423 is a multi zinc-finger transcription factor expressed in preadipocytes and mature adipocytes in vivo. Our recent work has revealed a critical role for Zfp423 in maintaining the fate of white adipocytes in adult mice through suppression of the beige cell thermogenic gene program; loss of Zfp423 in mature adipocytes of adult mice results in a white-to-beige phenotypic switch. However, the exact requirements of Zfp423 in the fetal stages of early adipose development in vivo have not been clarified. Method: Here, we utilize two models that confer adipose-specific Zfp423 inactivation during fetal adipose development (Adiponectin-Cre; Zfp423 loxP/loxP and Adiponectin-rtTA; TRE-Cre; Zfp423 loxP/loxP ). We assess the impact of fetal adipose Zfp423 deletion on the initial formation of adipose tissue and evaluate the metabolic consequences of challenging these animals with high-fat diet feeding. Results: Deletion of Zfp423 during fetal adipose development results in a different phenotype than is observed when deleting Zfp423 in adipocytes of adult mice. Inactivation of Zfp423 during fetal adipose development results in arrested differentiation, specifically of inguinal white adipocytes, rather than a white-to-beige phenotypic switch that occurs when Zfp423 is inactivated in adult mice. This is likely explained by the observation that adiponectin driven Cre expression is active at an earlier stage of the adipocyte life cycle during fetal subcutaneous adipose development than in adult mice. Upon high-fat diet feeding, obese adipose Zfp423-deficient animals undergo a pathological adipose tissue expansion, associated with ectopic lipid deposition and systemic insulin resistance. Conclusions: Our results reveal that Zfp423 is essential for the terminal differentiation of subcutaneous white adipocytes during fetal adipose tissue development. Moreover, our data highlight the striking adverse effects of pathological subcutaneous adipose tissue remodeling on visceral adipose function and systemic nutrient homeostasis in obesity. Importantly, these data reveal the distinct phenotypes that can occur when adiponectin driven transgenes are activated in fetal vs. adult adipose tissue.
INTRODUCTION
White adipocytes are the primary cell type in mammals for safe energy storage in the form of triglyceride. These cells are characterized by their large single (unilocular) lipid-droplet appearance and the presence of the enzymatic machinery to synthesize triglyceride for storage in times of energy surplus. White adipocytes also produce hormones and circulating cytokines (termed adipokines) that regulate food intake and nutrient homeostasis [1] . Brown and beige adipocytes are heat-producing, or "thermogenic," adipocytes that are characterized by their abundance of mitochondria and ability to burn stored energy to produce heat [2, 3] . This thermogenic capacity is mostly mediated by uncoupling protein 1 (Ucp1). Ucp1 is a transport protein that sits within the inner mitochondrial membrane and facilitates a proton leak [4] . The importance of white adipose tissue is highlighted by two seemingly disparate conditions. An absence of adipose tissue, or "lipodystrophy," results in the loss of protective adipokines (e.g. adiponectin and leptin) and ectopic lipid accumulation in non-adipose tissues such as the liver, muscle, and pancreas. The latter is deleterious to nutrient homeostasis, as excessive accumulation of lipid species can trigger insulin resistance and cardiovascular disease [5] . Increased adiposity, as seen in the condition of obesity, also confers significant risk for developing the same chronic disorders, including insulin resistance, diabetes mellitus, cardiovascular disease, and cancer. However, a significant portion of obese individuals appears relatively resistant to acquiring metabolic syndrome, at least for a period of time [6e8] . This suggests that additional factors, outside of increased adiposity per se, determine metabolic health in obesity. One clear predictor of metabolic disease in the setting of obesity is the cellularity of adipose depots [9, 10] . Adipose tissue expansion in obesity, in principle, can occur through increased lipid-loading into existing adipocytes, leading to increased cell size, or "adipocyte hypertrophy." Adipocyte hypertrophy is characteristic of adipose tissue in obese individuals with metabolic syndrome. The prevailing theory is that engorged fat cells outstrip their vascular supply, leading to local hypoxia, fibrosis, adipocyte dysfunction, and cell death [11e16] . Similar to what is observed in lipodystrophy, excess lipid is deposited in peripheral non-adipose tissues that are incapable of safely storing excessive amounts of triglyceride. Increases in fat cell number, or "adipocyte hyperplasia," can also occur in obese individuals, resulting in the accumulation of more numerous adipocytes at the expense of large hypertrophic adipocytes. "Healthy-obese" individuals, in comparison to BMI-matched individuals with metabolic syndrome, often exhibit an adipose phenotype characterized by smaller and more numerous adipocytes. This strongly correlates with low inflammation, fibrosis, and preservation of circulating levels of the insulin-sensitizing hormone adiponectin [17e19] . The storage of triglyceride over numerous adipocytes is believed to help limit the loss of adipocyte function. These observations imply that adipocyte recruitment is protective in obesity and that a pathological hypertrophic adipose expansion in obesity effectively creates a "partial lipodystrophic" phenotype. Clinical studies also point to the location of excess adipose accumulation as one of the best predictors of metabolic health. Individuals who preferentially store excess adiposity in the visceral compartment are at a greater risk than those who accumulate adipose tissue in the subcutaneous region [20] . In fact, subcutaneous adipose tissue appears protective against insulin resistance [21] . Some engineered mouse models preferentially accumulate subcutaneous WAT and exhibit a metabolically healthy obese phenotype [22, 23] . Thus, the preservation of functional subcutaneous WAT is widely believed to be critical for the maintenance of whole body metabolic homeostasis. However, the precise requirements of functional subcutaneous WAT in vivo have not been directly assessed, in large part because genetic tools to manipulate WAT in a depot-selective manner have been lacking. The main transcriptional machinery that governs adipogenesis has been carefully elucidated, largely using cell culture models [24e26]. The nuclear hormone receptor, Pparg, represents the key regulator of adipocyte differentiation [27] . We have previously identified the multi-C2H2 zinc-finger transcription factor, Zfp423, as a regulator of multiple stages of the adipocyte life cycle. Zfp423 expression identifies committed peri-endothelial preadipocytes that reside in the adipose tissue vasculature and contribute to white adipocyte hyperplasia associated with high-fat diet feeding [28, 29] . In cells, Zfp423 regulates preadipocyte commitment and differentiation, at least in part through regulation of preadipocyte levels of Pparg [30] . Zfp423 is also expressed in fully differentiated adipocytes; however, expression is higher in white adipocytes as compared to brown adipocytes. In mature white adipocytes, Zfp423 functions to suppress the thermogenic gene program, thereby maintaining the white adipocyte identity of these cells [31] . Genetic evidence supporting a critical role for Zfp423 in maintaining the white adipose lineage comes from our recent study in which we utilized a doxycycline-inducible system for Cre-mediated inactivation of Zfp423 in adult adipocytes (Adiponectin-rtTA; TRE-Cre; Zfp423 loxP/ loxP ; "Zfp423-iAKO" mice) [31] . Inducible adipocyte-specific inactivation of Zfp423 in adult mice leads to a robust conversion of mature white adipocytes into thermogenic, beige-like cells. These data revealed that Zfp423 is required in differentiated white adipocytes to suppress the thermogenic gene program and maintain the white adipocyte identity. However, clear genetic evidence supporting a role for Zfp423 in the initial formation of adipocytes has been lacking. [30] . However, the importance of Zfp423 to white adipose depot development could not be fully clarified given the other confounding phenotypes in this model. In this study, we reveal that the loss of adipose Zfp423 during fetal WAT development leads to arrested terminal differentiation of inguinal white adipocytes by the time of birth. Upon high-fat diet feeding as adults, Zfp423-deficient animals become obese but exhibit a metabolic phenotype similar to that of partial lipodystrophy, characterized by pathological inguinal WAT expansion, hepatic steatosis, and systemic insulin resistance. This developmental defect can be rescued by administering the Pparg ligand, rosiglitazone, specifically during the fetal and early postnatal period. All together, these data define Zfp423 as a critical regulator of adipose development and illustrate the systemic metabolic consequences of pathological subcutaneous adipose tissue expansion in obesity.
MATERIALS AND METHODS

Animals
The Pdgfra-Cre (stock# 013148), Adiponectin-Cre (stock# 010803), and Rosa26R loxP-stop-loxP-tdtomato transgenic strains were from Jackson lab. Zfp423 loxP/loxP mice were a generous gift from Dr. S. Warming (Genentech, Inc.) [34] . Adiponectin rtTA and TRE-Cre transgenic mice have been described previously [35] . Mice were maintained with a 12-hour light/dark cycle and free access to food and water. All animal experiments were performed according to procedures approved by the UTSW Institutional Animal Care and Use Committee.
Histological analysis
Tissues were dissected and fixed in 4% paraformaldehyde overnight. Paraffin processing, embedding, sectioning, and standard hematoxylin and eosin (H&E) staining were performed at the Molecular Pathology Core Facility at UTSW. Bright-field and fluorescent images were acquired using Keyence BZ-X710 microscope. Adipocyte size analysis was conducted following published protocols with minor modifications [36] . Keyence BZ-X Analyzer software was used for analysis based on bright-field images of H&E-stained paraffin sections. >300 adipocytes were quantified in each individual animal.
Indirect immunofluorescence
The following antibodies and concentrations were used: guinea pig anti-perilipin 1:1500 (Fitzgerald 20R-PP004); rabbit anti-F4/80 1:500 (Santa Cruz M-300); donkey anti-rabbit Alexa 647 1:200 (Invitrogen); and goat anti-guinea pig Alexa 488 1:200 (Invitrogen). Paraffin sections were dewaxed and hydrated in Xylene and 100%e95%e 80%e70%e50% Ethanol and ddH 2 O. Slides were placed in chambers containing 1Â R-Buffer Buffer A pH 6.0 solution and antigen retrieval was done using Antigen Retriever 2100 (Electron Microscopy Sciences) for 2 h. Following PBS wash for 5 min, Fx Signal Enhancer (Invitrogen) was added to the slides for 30 min at room temperature. Slides were then blocked for 30 min in PBS containing 10% normal goat serum at room temperature. Primary antibodies were then diluted in PBS containing 10% normal goat serum and added to paraffin sections overnight at 4 C. Following overnight incubation, slides were washed in PBS and incubated with secondary antibodies diluted in PBS containing 10% normal goat serum for 2 h at room temperature. Washed slides were mounted with Prolong Anti-Fade mounting medium containing DAPI (Invitrogen) before images were acquired for analysis.
2.4.
In vivo insulin stimulation After 6-hour fasting, animals were anesthetized and injected with insulin (1 U/kg for chow-fed mice; 2 U/kg for HFD-fed mice) through the portal vein. 5 min after the injection, iWAT, gWAT, and liver were quickly snap-frozen for subsequent analysis. Samples harvested before insulin injection were used as untreated controls.
Immunoblotting and antibodies
Protein extracts from cells or tissues were prepared by homogenization in RIPA lysis buffer (Santa Cruz). Protein extracts were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto PVDF membrane (Millipore). After incubation with the indicated primary antibodies at 4 C overnight, the blots were incubated with IR Dye-coupled secondary antibodies (LI-COR) and visualized by the LI-COR Odyssey infrared imaging system. The anti-pSer473-Akt (#9271) and anti-Akt (#9272) antibodies were from Cell Signaling. The anti-Adiponectin antibody was from Dr. P.E. Scherer (UTSW).
2.6. Isolation of adipose stromal vascular fraction (SVF) and in vitro differentiation White fat tissues dissected from mice (4e5 weeks of age) were washed in PBS, minced thoroughly, and digested in vacuum filtered digestion buffer (100 mM Hepes PH 7.4, 120 mM NaCl, 50 mM KCl, 5 mM glucose, 1 mM CaCl 2 , 1.5% bovine serum albumin, and 1 mg ml À1 collagenase D) for 2 h at 37 C with shaking. Digested tissues were then filtered through 100 mM cell strainers to remove undigested tissues. The flow-through was centrifuged for 5 min at 600 g to pellet the stromal vascular cells. 
RESULTS
Inactivation of
Zfp423 in the Pdgfra lineage leads to growth defects including arrested development of adipose tissue Recent insight into the identity and molecular characteristics of adipose precursor populations has begun to inform strategies to target the adipose lineage at early stages of tissue development. Expression of platelet-derived growth factor receptor a-chain (Pdgfra) identifies a pool of cells within the adipose tissue stroma that contains adipose precursors. Adipose precursors and all adipocytes in the major adipose depots appear to descend from cells with a history of Pdgfra expression [37] . Despite the widespread expression of endogenous Pdgfra in mesenchymal populations throughout the mouse, it is reported that one strain of the Pdgfra-Cre mice efficiently and specifically targets the adipose lineage and can be used for gene ablation at the level of adipose progenitors [37] . Therefore, in order to investigate the role of Zfp423 at the earliest stages of adipogenesis in vivo, we developed a mouse strain in which Zfp423 is inactivated specifically in the Pdgfra-lineage (Pdgfra Lin ) by crossing Pdgfra-Cre transgenic mice with mice carrying conditional (loxP-flanked) Zfp423 alleles (Pdgfra-Cre; Zfp423 loxp/loxp animals, denoted as "Pdgfra Lin -Zfp423-KO" mice). The Pdgfra Lin -Zfp423-KO mice were born in the expected Mendelian ratio; however, knockout mice were noticeably smaller in size (Supplementary Figure 1a) and most were not able to survive beyond 4e5 weeks of age. A significant reduction in white adipose depot mass was observed in Zfp423-deficient mice compared to control littermates (Supplementary Figure 1b) . mRNA levels of adipocyte-selective genes in both inguinal and gonadal WAT were significantly lower in knockout animals as compared to controls ( Supplementary Figures 1c and d) . These data are consistent with the hypothesis that Zfp423 is required for the formation of white adipose tissue. However, the striking growth defects in the animals suggest that Cre-mediated recombination of Zfp423 occurs outside the adipose lineage, thus confounding any further analysis with this model.
Inguinal adipose tissue development is impaired in
Adiponectin-Cre; Zfp423 loxP/loxP mice Hong et al. recently identified a population of proliferating Pdgfra þ preadipocytes that emerge in the inguinal WAT depot at E16.5 of development [38] . Interestingly, by E18.5, these cells express adipose progenitor markers (e.g. CD34, CD29, CD24) but also express perilipin and adiponectin; the latter two genes are largely restricted to mature adipocytes after birth. In support of this observation, the authors demonstrate that the Adiponectin-Cre transgene targets a subset of adipose stromal vascular cells in fetal inguinal WAT. These targeted stromal cells likely represent actively differentiating or highly committed preadipocytes. This stands in contrast to the expression pattern of Cre in adult Adiponectin-Cre mice. In postnatal WAT depots, Cre expression is restricted to fully mature adipocytes [37] . Figures 2f and g ) or in the SVF of developing gonadal WAT at postnatal day 6 (P6) (Supplementary Figure 2h) . These data indicate that during fetal inguinal WAT development, the adiponectin promoter is active at an earlier stage of the differentiation program than previously recognized. In contrast, adiponectin expression after birth is restricted to mature lipid-laden adipocytes. Based on this observation and aforementioned published results, we reasoned that the adiponectin-Cre transgene would target floxed alleles in either the fetal precursor stage or as cells are actively undergoing differentiation. This would allow for targeted disruption of Zfp423 in the developing inguinal WAT depot and provide a tool to investigate the function of Zfp423 during the terminal differentiation of adipocytes and fetal development of inguinal WAT. Thus, we bred adiponectin-Cre transgenic mice with Zfp423 loxP/loxP animals (Adiponectin-Cre; Zfp423 loxp/loxp animals, denoted herein as Zfp423-AKO mice) ( Figure 1A ). Zfp423-AKO mice were born in the expected Mendelian ratio and exhibited similar growth rate in comparison with control littermates. However, mRNA levels of Pparg2 and other adipocyte-selective genes in both inguinal WAT and fractionated inguinal adipocytes were significantly lower in Zfp423-AKO mice ( Figure 1B; Supplementary Figure 3a) . Histological analysis of inguinal fat depots isolated from Zfp423-AKO animals revealed the appearance of patches of adipocytes, which were smaller in size, loaded with less lipid, and lacked the signature unilocular white adipocyte morphology (Figure 1CeJ ). This phenotype differs significantly from the inducible model in which adipocyte-specific deletion of Zfp423 induced in adult mice leads to a robust white-to-beige adipocyte conversion (w200-fold increase in Ucp1 mRNA), without impacting the fat cell phenotype per se [31] . In sharp contrast, the expression of thermogenic genes Ucp1, Cidea, and Prdm16 in iWAT of Zfp423-AKO mice was only marginally higher (<2-fold) than the expression found in controls ( Supplementary Figures 3a and b) . The lower expression of Pparg and other adipocyte-selective genes in purified adipocytes suggests that fetal inguinal adipocytes fail to fully undergo terminal differentiation in the absence of Zfp423. These data suggest that indeed Cre activity occurs at an earlier stage of the adipocyte life cycle than it does in adult mice and that the formation of a fully mature adipocyte is needed before Zfp423-deficiency can trigger an induction of the thermogenic gene program. Next, we assessed the overall functionality of the inguinal WAT depot in control and Zfp423-AKO mice. First, we tested the responsiveness of adipose depots to insulin stimulation, as reflected by the activation of its downstream signal transducer, Akt (phosphorylated-AKT). As compared to control animals, insulin-induced Akt phosphorylation was significantly impaired in the inguinal WAT of Zfp423-AKO mice ( Figure 1K ). Moreover, the lipolytic capacity of Zfp423-deficient adipose tissue was impaired. Isolated inguinal WAT depots from Zfp423-AKO mice released significantly less glycerol as compared to control inguinal WAT upon stimulation by the b3-adrenergic receptor agonist CL316243 ( Figure 1L ). These data provide functional evidence that inguinal WAT depots of Zfp423-AKO mice are not fully mature and developed. Levels of Zfp423 were significantly lower in the gonadal WAT depot as well as the interscapular brown adipose tissue depot of Zfp423-AKO mice ( Supplementary Figures 3c and d) , consistent with the known activity of the adiponectin-Cre transgene in all adipose depots. However, none of the abnormalities observed in the inguinal WAT depots of Zfp423-AKO mice was found in the gonadal WAT depot or interscapular brown adipose tissue (BAT) depot (Supplementary Figuers  3ceh) . This could imply a depot-selective requirement of Zfp423 during adipose tissue development. However, based on the differential activity of the adiponectin-Cre transgene in precursors of different depots, Cre-mediated deletion of Zfp423 likely occurred later in the differentiation program of gonadal white adipocytes and interscapular brown adipocytes. In fact, the expression of the thermogenic gene program was elevated in the gWAT of Zfp423-AKO mice (Supplementary Figure 3c) , similar to the gonadal WAT phenotype found in the previously reported inducible adult adipocyte-specific Zfp423 knockout model. Baseline levels of these same thermogenic genes in the BAT were not impacted by the loss of Zfp423 (Supplementary Figure 3d) .
3.3. Developmental defects caused by Zfp423-deficiency are cell autonomous and can be rescued by Pparg agonism Next, we evaluated whether the observed defects in inguinal WAT development and function were largely due to a cell autonomous role for Zfp423 in adipocyte differentiation. We isolated and established Original Article cultures of the stromal vascular fraction (SVF) of inguinal WAT of control and Zfp423-AKO mice. In vitro adipocyte differentiation from cultured cells was induced using the standard 3T3-L1 adipogenic cocktail containing dexamethasone, IBMX and insulin. Differentiated cultures from both genotypes appeared equally capable of accumulating lipid, as indicated by Oil Red O staining (Figure 2A) . However, mRNA levels of Pparg2 and other genes selective to mature adipocytes (adiponectin, adipsin, and C/ebpa) were consistently reduced in the Zfp423-deficient cells ( Figure 2B ). These data suggest that the loss of Zfp423 expression after the onset of adiponectin/Cre Figure 2C ). Collectively, these results provide evidence that Zfp423 is required for the terminal differentiation of inguinal white adipocytes and the fetal development of this WAT depot. We previously reported that Zfp423 regulates Pparg expression in 3T3 fibroblast cell lines [30] . Consistent with these data, Pparg2 expression was lower in freshly isolated or in vitro derived Zfp423-deficient adipocytes from Zfp423-iAKO mice ( Figures 1B and 2B) . However, Pparg expression in Zfp423-deficient adipocytes was not completely absent. Thus, we asked whether agonism of the remaining Pparg in Zfp423 knockout adipocytes is sufficient to rescue the defects in white adipocyte differentiation and function. First, we performed in vitro differentiation assays with the Pparg agonist rosiglitazone added to the differentiation media. Under this condition, adipocyte cultures from both groups appeared equally differentiated ( Figure 2A) ; no statistically significant differences in mRNA levels of adipocyte-selective genes were observed ( Figure 2B) . Moreover, the CL316423-induced lipolytic capacity of Zfp423-deficient cells was restored by rosiglitazone treatment (Figure 2C ), suggesting that the rescue of Pparg activity by its agonist was largely sufficient to correct the differentiation defects caused by Zfp423-deficiency. Consistent with this observation, the expression of the thermogenic gene program in rescued Zfp423-deficient adipocyte cultures is strongly induced ( Figure 2B ). This phenotype is now similar to adipocyte cultures in which Zfp423 is inactivated post-differentiation. We also tested the ability of rosiglitazone to rescue the observed defects in inguinal WAT development in vivo. Inguinal adipocytes begin to appear around embryonic day 16 (E16) and most adipocytes are formed by postnatal day 5 (P5) [35] . Thus, we administered vehicle or rosiglitazone to control and Zfp423-AKO animals from E16 to P5 via gavage of pregnant and lactating mothers ( Figure 3A) . At P5, iWAT from vehicle-treated Zfp423-AKO pups appeared poorly differentiated; numerous patches of small, lipid-devoid cells were apparent (Figure 3BeE) , and levels of all adipocyte-selective genes were lower than in vehicle-treated control mice ( Figure 3J ). However, none of these developmental defects was observed in Zfp423-AKO pups exposed to rosiglitazone during the peri-natal period. Compared to iWAT from rosiglitazone-treated control mice, iWAT from rosiglitazonetreated knockout mice exhibits a normal morphology (Figure 3FeI ) and expresses comparable levels of adipocyte-selective genes ( Figure 3J ). Thus, we reasoned that these rescued animals are now essentially similar to the aforementioned model in which Zfp423 is inactivated in adipocytes of adult mice. Indeed, the thermogenic gene program was strongly induced in the rescued Zfp423-AKO mice ( Figure 3K ). Altogether, these data provide genetic evidence that Zfp423 is a critical regulator of the fetal development of inguinal white adipose tissue, serving as an upstream activator of Pparg expression.
3.4.
Inguinal WAT of Zfp423-deficient mice undergoes a pathological adipose tissue expansion upon high-fat diet feeding In the setting of caloric excess, a lack of functional adipocytes can lead to inappropriate lipid handling in adipose tissue and/or altered adipokine production. This can subsequently lead to an accumulation of lipids in non-adipose organs. Ectopic storage of lipids can be deleterious ("lipotoxicity") and trigger the development of insulin resistance [39] . The poor development of the inguinal WAT depot in Zfp423-AKO mice prompted us to challenge the animals with an obesogenic highfat diet (60% kcal from fat). Control and littermate male Zfp423-AKO mice were administered high-fat diet feed beginning from 5 weeks of Original Article age. The control and Zfp423-deficient mice equally gained weight over the first 8 weeks of the high-fat diet regimen ( Figure 4A ). Afterwards, Zfp423-deficient animals gained slightly more weight than controls; however, by the end of the 16 week period, these differences in weight measurements did not reach statistical significance ( Figure 4A ). Analysis of Zfp423 knockout mice at 8 weeks of age revealed differences in adipose tissue size and morphology. Weights of inguinal, but not gonadal or mesenteric, fat depots of Zfp423-deficient mice were higher than the weights of control inguinal adipose tissues ( Figure 4B ). Histological analysis revealed a striking inguinal WAT phenotype with hallmarks of unhealthy adipose expansion ( Figure 4C and D) . Many small adipocytes devoid of lipids were observed in knockout animals, similar to what was observed in depots from chow-fed animals. However, the frequency of large, hypertrophic adipocytes was greater in the Zfp423-AKO mice ( Figure 4E ). Overall, the average adipocyte size was approximately 40% higher than found in controls ( Figure 4F ). This hypertrophic adipose phenotype was accompanied by increased inflammation, as assessed by the increased presence of crown-like immune structures ( Figure 4G ). Moreover, higher expression levels of immune cell selective genes and relatively lower expression of adipocyte-selective genes were detected in total inguinal WAT tissue ( Figure 4H and I) . After 8 weeks of high-fat diet feeding, the gonadal WAT appeared similar in mass to corresponding depots from control animals ( Figure 4B ). No significant differences in gonadal adipocyte cell size were observed between the two groups ( Supplementary  Figure 4a) . However, there was an abundance of crown-like structures in this depot of Zfp423-AKO mice (Supplementary Figures 4b and  c) , correlating with increased expression of immune cell transcripts in whole gonadal white adipose tissue (Supplementary Figure 4d) . Chronic adipose inflammation is typically associated with adipose tissue dysfunction. Indeed, in Zfp423-AKO mice, insulin-stimulated AKT phosphorylation was blunted in both inguinal and gonadal WAT depots (Supplementary Figure 4f) , and serum levels of adiponectin were significantly lower after 8 and 16 weeks of high-fat diet feeding (Supplementary Figure 4g) .
Unhealthy adipose tissue expansion is often associated with systemic alterations in nutrient handling. Consistent with this notion, we observed higher levels of serum triglycerides in Zfp423-AKO mice than in controls, both after 8 and 16 weeks of high-fat diet feeding ( Figure 5A and B) . This correlated with a progressive increase in hepatic steatosis (Figure 5CeF ) and resistance to insulin-induced AKT activation ( Figure 5G ) in the knockout animals. Glucose and insulin tolerance tests revealed systemic impairments in glucose homeostasis in Zfp423-AKO mice. Zfp423-AKO mice were less glucose tolerant than control animals and less sensitive to the actions of insulin ( Figure 5H and I) . All together, the ectopic lipid accumulation, lower serum adiponectin levels, glucose intolerance, and insulin resistance indicate that obese Zfp423-deficient animals exhibit the metabolic profile commonly observed in lipodystrophy. 3.5. Pathological expansion of subcutaneous WAT is sufficient to trigger gonadal WAT dysfunction and impaired systemic nutrient homeostasis Defects in adipose development in Zfp423-AKO mice were restricted to the subcutaneous inguinal WAT depot; however, upon high-fat diet feeding, systemic insulin resistance was apparent and gonadal WAT also appears dysfunctional. These data suggest that a pathological remodeling specifically of subcutaneous WAT in obesity is sufficient to drive intra-abdominal WAT dysfunction and systemic nutrient imbalance. In order to test this hypothesis, we utilized our doxycycline- ) specifically during E16 to P5 of life and then harvested animals at 5 weeks of age for analysis ( Figure 6A ). As expected, Zfp423 mRNA levels were significantly reduced in the inguinal WAT depot and interscapular BAT of Zfp423-iAKO mice (Supplementary Figure 5a) . However, levels of Zfp423 in the gonadal WAT were not reduced ( Supplementary  Figure 5b) . Similar to the Zfp423-AKO mice described above, the inguinal WAT did not appear fully developed, as revealed by the large regions of undifferentiated cells ( Supplementary Figures 5d and e) and the lower expression of adipocyte-selective genes in the tissue (Supplementary Figure 5a) . Importantly, brown adipose tissue and gonadal WAT appeared indistinguishable from controls ( Supplementary  Figure 5c , fei). At five weeks of age we challenged the inducible Zfp423 knockout model (herein, "Zfp423-fetalAKO") to high-fat diet feeding ( Figure 6B ). After 8 weeks of high-fat diet feeding, many of the phenotypes observed in the obese Zfp423-AKO mice were again apparent. Body weights of Zfp423-fetalAKO mice were indistinguishable from control animals ( Figure 6C) ; however, inguinal WAT had an unhealthy appearance, characterized by adipocyte hypertrophy, increased inflammation, and lower levels of adipocyte-selective transcripts (Figure 6DeI) . The expression levels of Zfp423 and other adipocyte genes remained unaltered in Zfp423-fetalAKO gWAT ( Figure 7D) ; however, there was an abundant number of crown-like structures, correlating with the elevated levels of transcripts encoding immune cell markers in the gonadal depot of the knockout mice (Figure 7AeC) . Functionally, both inguinal and gonadal WAT of the Zfp423-fetalAKO mice appeared relatively more resistant to the actions of insulin. Insulin-stimulated p-AKT induction was strongly blunted in both depots ( Figure 7E ). Hepatic insulin resistance was also apparent (Figure 7E ), correlating with increased hepatic steatosis and serum triglycerides (Figure 7FeH ). Intraperitoneal glucose and insulin tolerance tests revealed that Zfp423-fetalAKO mice were more glucose intolerant and insulin resistant than controls ( Figure 7I and J). These phenotypes of Zfp423-fetalAKO mice may be explained, at least in part, by the largely reduced levels of serum adiponectin ( Figure 7K ). This model of inguinal-selective Zfp423-inactivation largely recapitulated the metabolic phenotype observed in Zfp423-AKO animals. These data strongly suggest that pathological subcutaneous WAT expansion in adult obesity, triggered initially by poor fetal adipocyte differentiation, is sufficient to considerably impair visceral WAT function and systemic glucose and lipid metabolism. 
DISCUSSION
We recently demonstrated that Zfp423 maintains the mature white adipocyte phenotype through suppression of the adipocyte thermogenic gene program. This was demonstrated by targeting mature adipocytes in adult animals through use of the doxycycline-inducible Adiponectin-rtTA transgene. Here, we use the same genetic system or the commonly used constitutively active Adiponectin-Cre allele and observe a vastly different phenotype when gene ablation is induced during fetal adipose development. When Zfp423 is removed from mature adipocytes of adult animals, a white-to-beige phenotypic switch is observed. When Zfp423 is removed from precursors and/or actively differentiating cells, we observe a defect in the terminal differentiation of fetal white adipocytes (Figure 8 ). This is apparent by the lack of lipid accumulation and lower expression of Pparg and adipocyte-selective genes. The inability of the thermogenic gene program to activate in these Zfp423-deficient cells is likely due to the reduction in Pparg expression. This discrepancy in the phenotypes is likely attributable to the fact that Adiponectin-Cre is active during fetal inguinal adipocyte differentiation while only active in fully mature adipocytes in adult animals. These data highlight the emerging notion that fetal adipose precursors appear distinct from adult adipose precursors, highlighted in part by the expression of adiponectin, perilipin, and perhaps other genes [38, 40] . Moreover, these data highlight a critical role for Zfp423 in both the establishment and maintenance of the white adipose lineage. The data presented here highlight some of the pros and cons of the various genetic tools now available for manipulating genes within the adipose lineage. The Pdgfra-Cre line targets the adipose precursors and descending adipocytes with high efficiency; however, use of these mice as a tool may depend on the expression pattern of the floxed gene of interest. The Adiponectin-Cre line developed by Rosen and colleagues is undoubtedly the most specific and efficient tool for adipose targeting [41] ; however, the data here highlight that Cree mediated recombination in these mice is not entirely confined to fully differentiated adipocytes. During fetal inguinal WAT development, Cre expression occurs in cells that are most likely either highly committed preadipocytes or actively differentiating cells. Further analysis of these cells will be needed to understand their properties. After birth, Cre expression appears limited to mature, lipid-laden adipocytes, at least in the depots examined. Thus, the timing of Cre expression in the different depots of these animals has to be considered when interpreting results. As such, our results can only confirm an important role for Zfp423 in the onset of fetal subcutaneous WAT development. Zfp423 expression marks perivascular adipose precursors in adult mice; however the requirement of this factor in adult adipocyte differentiation in vivo, particularly in intra-abdominal depots, still remains unknown and will require the use of additional models. Importantly, models allowing inducible expression of Cre recombinase, such as the Tet-on system employed here, allow for gene function to be dissected at various stages of life. Furthermore, timing the doxycycline treatment allows white adipose depots to be targeted in a selective manner. Clinical studies over the past decade have revealed a striking correlation between adipose tissue cellularity and metabolic health in the setting of obesity. The phenotypes of the Zfp423-AKO mice presented here fit well with clinical observations and highlight the importance of adipogenesis to healthy WAT remodeling and nutrient homeostasis in obesity. Poor fetal development of the inguinal WAT depot in Zfp423 knockout mice leads to an expanded subcutaneous depot in obese adults that resemble WAT depots of obese humans with metabolic syndrome. This pathological expansion is characterized by adipocyte hypertrophy, inflammation, and loss of insulin sensitivity. The observed adipocyte hypertrophy may be due to the observed defects in lipolytic capacity of the Zfp423-deficient adipocytes. It is also possible that remaining adipocytes become hypertrophied as an attempt to compensate for the lack of differentiated adipocytes. Clinically, and as observed in our animal models, these adipose phenotypes correlate with low serum adiponectin, high serum triglycerides, and systemic insulin resistance. Adipose tissue distribution is also a reliable predictor of metabolic health. Preferential expansion of subcutaneous depots is often observed in the "healthy" obese populations. Interestingly, overall inguinal WAT mass was increased in the Zfp423-AKO mice. This suggests that subcutaneous adipose tissue quality is equally, if not more, important than adipose tissue quantity. This may also appear true for visceral adipose tissue. Senol-Cosar et al. recently reported that transgenic expression of tenomodulin in adipose tissue results in a healthy visceral WAT expansion, characterized by increased preadipocyte proliferation and lower inflammation and fibrosis, despite expanded gonadal WAT mass [42] . Our inguinal WAT-selective model of Zfp423 ablation sheds further insight into the importance of healthy subcutaneous WAT by illustrating the systemic metabolic consequences of pathological subcutaneous adipose tissue expansion in obesity. A better understanding of how poor adipogenesis leads to pathological adipose remodeling may lead to novel therapeutic strategies to improve adipose tissue health in obesity.
